Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial
Dréno, Brigitte, Prof, Kunstfeld, Rainer, Prof, Hauschild, Axel, Prof, Fosko, Scott, Prof, Zloty, David, MD, Labeille, Bruno, MD, Grob, Jean-Jacques, Prof, Puig, Susana, MD, Gilberg, Frank, PhD, Bergström, Daniel, PhD, Page, Damian R, PhD, Rogers, Gary, MD, Schadendorf, Dirk, Prof
Published in The lancet oncology (01.03.2017)
Published in The lancet oncology (01.03.2017)
Get full text
Journal Article
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
Basset-Seguin, Nicole, Prof, Hauschild, Axel, Prof, Grob, Jean-Jacques, Prof, Kunstfeld, Rainer, Prof, Dréno, Brigitte, Prof, Mortier, Laurent, Prof, Ascierto, Paolo A, Prof, Licitra, Lisa, MD, Dutriaux, Caroline, MD, Thomas, Luc, Prof, Jouary, Thomas, MD, Meyer, Nicolas, MD, Guillot, Bernard, Prof, Dummer, Reinhard, Prof, Fife, Kate, MD, Ernst, D Scott, Prof, Williams, Sarah, MSc, Fittipaldo, Alberto, MD, Xynos, Ioannis, MD, Hansson, Johan, Prof
Published in The lancet oncology (01.06.2015)
Published in The lancet oncology (01.06.2015)
Get full text
Journal Article